2018-02-22
Calcitonin gene-related peptide (receptor) antibodies: An exciting avenue for migraine treatment
Publication
Publication
Genome Medicine , Volume 10 - Issue 1
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
| Additional Metadata | |
|---|---|
| doi.org/10.1186/s13073-018-0524-7, hdl.handle.net/1765/104914 | |
| Genome Medicine | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Maassen Van Den Brink, A. (Antoinette), Terwindt, G., & Maagdenberg, A. (2018). Calcitonin gene-related peptide (receptor) antibodies: An exciting avenue for migraine treatment. Genome Medicine (Vol. 10). doi:10.1186/s13073-018-0524-7 |
|
